Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

OMPHI1

OVERVIEW

The Oxford Maternal & Perinatal Health Institute (OMPHI) works alongside Nuffield Department of Women's & Reproductive Health to bring together world experts to resolve priority maternal and perinatal health problems on a global scale, such as the INTERGROWTH-21ST, INTERBIO 21ST AND INTERPRACTICE-21ST studies.

Intergrowth 21st

OMPHI also includes the recent INTERCOVID study https://intergrowth21.tghn.org/intercovid/ a large, multi-national, prospective cohort study taking place in eighteen countries, with the aim of assessing the effect of COVID-19 in pregnancy on maternal, fetal and neonatal outcomes worldwide.

You can find details of the Institute and the studies on the dedicated web-page here.

Intelligent Imaging

Return to Intelligent Imaging in Fetal Health here

Our Team

  • Aris Papageorghiou
    Aris Papageorghiou

    Professor of Fetal Medicine and Director of Research of the Oxford Maternal and Perinatal Health Institute (OMPHI).

  • Rachel Craik
    Rachel Craik

    Project Manager for Collaborative Global Ultrasound Studies

  • Jehan Karim
    Jehan Karim

    Clinical Research Fellow